Hypoxic Induction of Vasculogenic Mimicry in Hepatocellular Carcinoma: Role of HIF-1 α, RhoA/ROCK and Rac1/PAK Signaling

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2020 Jan 15

PMID 31931758

Citations 29

Authors

Ji-Gang Zhang

He-Ming Zhou

Xue Zhang

Wan Mu

Juan-Ni Hu

Gao-Lin Liu

Qin Li

Affiliations

Soon will be listed here.

Abstract

Background: Vasculogenic mimicry (VM), defined as a capability of aggressive tumor Cells to mimic embryonic vasculogenic networks, caused poor prognosis in hepatocellular carcinoma (HCC). Rho kinases (ROCK), p21-activated kinase (PAK), hypoxia or epithelial-mesenchymal transition (EMT) contributed to the VM potential. However, the details underlying these biological behaviors have not been completely elucidated.

Methods: Kaplan-Meier analysis was conducted to predict relationship with hypoxia Inducible factor (HIF-1α), EMT related markers: Vimentin and patient prognosis. CD34/periodic acid-Schiff (PAS) double staining was examined to differentiate VM-positive (VM+) and VM-negative (VM-) samples. Cells were cultured under controlled hypoxic environments (1% O2) or normoxic conditions. The effect of hypoxia on RhoA/ROCK, Rac1/PAK and EMT were evaluated by real time-qPCR and western blot. HIF-1α small interfering RNA (siRNA), overexpressed or short hairpin RNA (shRNA) of ROCK and kinase inhibitors were used to explore the effect of HIF-1α, RhoA/ROCK, Rac1/PAK and Vimentin on VM.

Results: HIF-1α or Vimentin was upregulated in VM+ HCC tissues, compared to non-cancerous tissues (P < 0.01), and patients with high expression of HIF-1α or Vimentin had worse prognosis (P < 0.001). We showed hypoxia induced RhoA/ROCK and Rac1/PAK signaling transduction, and EMT could be repressed by HIF-1α siRNA. Notably, RhoA/ROCK or Rac1/PAK stabilized HIF-1α in hypoxia, whereas HIF-1α did not significantly altered RhoA/ROCK or Rac1/PAK signaling in hypoxia. Moreover, we found distinct roles of ROCK1, ROCK2 and PAK in regulating Vimentin phosphorylation.

Conclusions: RhoA/ROCK and Rac/PAK signaling played crucial roles in hypoxia-induced VM via Ser72 and Ser56 Vimentin phosphorylation in HCC.

Citing Articles

A comprehensive review of Schisandrin B's preclinical antitumor activity and mechanistic insights from network pharmacology.

Fang Y, Pan J, Wang P, Wang R, Liang S Front Pharmacol. 2025; 16:1528533.

PMID: 39995410 PMC: 11847788. DOI: 10.3389/fphar.2025.1528533.

Role of Rac1 in p53-Related Proliferation and Drug Sensitivity in Multiple Myeloma.

Matsumura I, Oda T, Kasamatsu T, Murakami Y, Ishihara R, Ohmori A Cancers (Basel). 2025; 17(3).

PMID: 39941828 PMC: 11815915. DOI: 10.3390/cancers17030461.

Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinoma.

Yang J, Yang J, Fang R, Sai W, Yao D, Yao M World J Hepatol. 2025; 16(12):1480-1492.

PMID: 39744196 PMC: 11686543. DOI: 10.4254/wjh.v16.i12.1480.

The role of N6-methyladenosine modification in tumor angiogenesis.

Qin L, Zeng X, Qiu X, Chen X, Liu S Front Oncol. 2024; 14:1467850.

PMID: 39691597 PMC: 11649548. DOI: 10.3389/fonc.2024.1467850.

RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential.

Ning Y, Zheng M, Zhang Y, Jiao Y, Wang J, Zhang S Cancer Cell Int. 2024; 24(1):339.

PMID: 39402585 PMC: 11475559. DOI: 10.1186/s12935-024-03519-7.

References

Boreddy S, Sahu R, Srivastava S . Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3. PLoS One. 2011; 6(10):e25799. PMC: 3189946. DOI: 10.1371/journal.pone.0025799. View

Chang F, Lemmon C, Park D, Romer L . FAK potentiates Rac1 activation and localization to matrix adhesion sites: a role for betaPIX. Mol Biol Cell. 2006; 18(1):253-64. PMC: 1751318. DOI: 10.1091/mbc.e06-03-0207. View

Chen M, Lee C, Huang W, Chou T . Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Biochem Pharmacol. 2013; 85(9):1278-87. DOI: 10.1016/j.bcp.2013.02.009. View

Turcotte S, Desrosiers R, Beliveau R . HIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma. J Cell Sci. 2003; 116(Pt 11):2247-60. DOI: 10.1242/jcs.00427. View

Ridley A . Rho GTPases and cell migration. J Cell Sci. 2001; 114(Pt 15):2713-22. DOI: 10.1242/jcs.114.15.2713. View

Zhang J, Li X, Wang Y, Zhang Q, Gu S, Wu X . ROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell line. PLoS One. 2014; 9(9):e107661. PMC: 4169566. DOI: 10.1371/journal.pone.0107661. View

Xu M, Zheng Y, Xie X, Liang J, Pan F, Zheng S . Sorafenib blocks the HIF-1α/VEGFA pathway, inhibits tumor invasion, and induces apoptosis in hepatoma cells. DNA Cell Biol. 2014; 33(5):275-81. DOI: 10.1089/dna.2013.2184. View

Bruick R, McKnight S . A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001; 294(5545):1337-40. DOI: 10.1126/science.1066373. View

Yang J, Zhu D, Zhou X, Yin N, Zhang Y, Zhang Z . HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter. Oncotarget. 2017; 8(29):47801-47815. PMC: 5564606. DOI: 10.18632/oncotarget.17999. View

10.

Takata K, Morishige K, Takahashi T, Hashimoto K, Tsutsumi S, Yin L . Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells. Mol Cancer Ther. 2008; 7(6):1551-61. DOI: 10.1158/1535-7163.MCT-07-0428. View

11.

Xiong N, Li S, Tang K, Bai H, Peng Y, Yang H . Involvement of caveolin-1 in low shear stress-induced breast cancer cell motility and adhesion: Roles of FAK/Src and ROCK/p-MLC pathways. Biochim Biophys Acta Mol Cell Res. 2016; 1864(1):12-22. DOI: 10.1016/j.bbamcr.2016.10.013. View

12.

Rane C, Minden A . P21 activated kinases: structure, regulation, and functions. Small GTPases. 2014; 5. PMC: 4160339. DOI: 10.4161/sgtp.28003. View

13.

Giannelli G, Koudelkova P, Dituri F, Mikulits W . Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016; 65(4):798-808. DOI: 10.1016/j.jhep.2016.05.007. View

14.

Riento K, Ridley A . Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003; 4(6):446-56. DOI: 10.1038/nrm1128. View

15.

Shimizu Y, Thumkeo D, Keel J, Ishizaki T, Oshima H, Oshima M . ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles. J Cell Biol. 2005; 168(6):941-53. PMC: 2171774. DOI: 10.1083/jcb.200411179. View

16.

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

17.

Sun T, Zhao N, Zhao X, Gu Q, Zhang S, Che N . Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology. 2009; 51(2):545-56. DOI: 10.1002/hep.23311. View

18.

Leong S, Faux C, Turbic A, Dixon K, Turnley A . The Rho kinase pathway regulates mouse adult neural precursor cell migration. Stem Cells. 2011; 29(2):332-43. DOI: 10.1002/stem.577. View

19.

Sin W, Chen X, Leung T, Lim L . RhoA-binding kinase alpha translocation is facilitated by the collapse of the vimentin intermediate filament network. Mol Cell Biol. 1998; 18(11):6325-39. PMC: 109219. DOI: 10.1128/MCB.18.11.6325. View

20.

Burrows N, Babur M, Resch J, Williams K, Brabant G . Hypoxia-inducible factor in thyroid carcinoma. J Thyroid Res. 2011; 2011:762905. PMC: 3134378. DOI: 10.4061/2011/762905. View